Trials / Completed
CompletedNCT02004717
Phase 1 Study of DS-8895a in Subjects With Advanced Solid Tumors
Phase 1, Open-label Study to Assess the Safety, Tolerability, and Pharmacokinetics of DS-8895a in Subjects With Advanced Solid Tumors
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 37 (actual)
- Sponsor
- Daiichi Sankyo Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
This is an open-label, sequential dose escalation and expansion study to evaluate the safety, tolerability, and pharmacokinetics of DS-8895a in Japanese subjects with advanced solid tumors.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DS-8895a |
Timeline
- Start date
- 2013-10-01
- Primary completion
- 2017-02-01
- Completion
- 2017-02-01
- First posted
- 2013-12-09
- Last updated
- 2019-07-22
Locations
2 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT02004717. Inclusion in this directory is not an endorsement.